Our goal is to analyze the molecular mechanisms that underlie the formation of tubulointerstitial (TI) fibrosis, to devise more effective therapies to prevent its progression. We study the collagen receptor integrins ?1?1 and showed that it downregulates collagen synthesis, and its loss leads to increased glomerular fibrosis following injury. Integrin ?1?1 plays an anti-fibrotic action by negatively regulating the phosphorylation state of pro-fibrotic growth factor receptors via activation of the tyrosine phosphatase TCPTP. We have also found that integrin ?1?1 is a negative regulator of TI fibrosis, as integrin ?1KO mice show increased unilateral ureteral obstruction-induced fibrosis. Moreover, integrin ?1KO collecting duct (CD) cells have increased activation of TGF-? receptor (T?R)-dependent pro-fibrotic signaling, such as phosphorylated Smad3 and collagen levels. TGF-? exerts its functions via activation of the serine/threonine kinases T?RI and T?RII. Binding of TGF-? to T?RII leads to phosphorylation of T?RI and subsequent activation of the major pro-fibrotic mediator Smad3. Interestingly, the cytoplasmic tail of T?RII can also be phosphorylated on tyrosine residues. However, whether these tyrosines play any physiological or pathological role in renal cells is unknown. The novelty of this proposal is that integrin ?1KO CD cells show increased basal levels of tyrosine phosphorylated T?RII. This result suggests that, in renal cells, integrin ?1?1 crosstalks with T?RII and it might prevent its pro-fibrotic action by downregulating its tyrosine phosphorylation levels. Interestingly, inhibition of TCPTP in CD cells leads to increased Smad3 activation and collagen synthesis. This result, together with the finding that 3 tyrosines in the T?RII tail can be potential substrates of TCPTP, forms the hypothesis that integrin ?1?1 negatively regulates T?RII tyrosine phosphorylation via activation of TCPTP. Thus, we propose that integrin ?1?1/TCPTP-mediated dephosphorylation of T?RII represents an important, but previously undescribed mechanism to selectively reduce T?RII activation and consequent progression of fibrosis. To test this hypothesis:
Aim 1 will analyze the role of T?RII-mediated pro-fibrotic signaling in TI injury in the integrin ?1KO mice. We will cross integrin ?1KO mice with global null or floxed Smad3 mice to determine if preventing T?R/Smad3 axis in the collecting system is sufficient to ameliorate TI fibrosis in the ?1KO mice. We will then determine if in vivo activation of TCPTP is beneficial in the setting of TI injury by counteracting T?R-mediated pro-fibrotic action.
Aim 2 will determine the mechanisms whereby integrin ?1?1 negatively regulates T?RII. We will use in vitro approaches to analyze i) if TCPTP directly binds and dephosphorylates T?RII;ii) if tyrosine residues are important to control T?RII-mediated Smad3 activation and collagen synthesis;and iii) which tyrosine(s) controls T?RII-mediated functions. This study will lead to the identification of a novel crosstalk between integrin ?1?1 an T?RII and, most importantly, a novel mechanism whereby T?RII-mediated pro-fibrotic signaling can be negatively modulated.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK095761-02
Application #
8649036
Study Section
Pathobiology of Kidney Disease Study Section (PBKD)
Program Officer
Rys-Sikora, Krystyna E
Project Start
2013-04-08
Project End
2017-03-31
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
2
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Nashville
State
TN
Country
United States
Zip Code
37212
Mickiewicz, Beata; Shin, Sung Y; Pozzi, Ambra et al. (2016) Serum Metabolite Profiles Are Altered by Erlotinib Treatment and the Integrin α1-Null Genotype but Not by Post-Traumatic Osteoarthritis. J Proteome Res 15:815-25
Kang, Li; Mokshagundam, Shilpa; Reuter, Bradley et al. (2016) Integrin-Linked Kinase in Muscle Is Necessary for the Development of Insulin Resistance in Diet-Induced Obese Mice. Diabetes 65:1590-600
Borza, Corina M; Su, Yan; Tran, Truc-Linh et al. (2016) Discoidin domain receptor 1 kinase activity is required for regulating collagen IV synthesis. Matrix Biol :
Elias, Bertha C; Das, Amrita; Parekh, Diptiben V et al. (2015) Cdc42 regulates epithelial cell polarity and cytoskeletal function during kidney tubule development. J Cell Sci 128:4293-305
Yazlovitskaya, Eugenia M; Tseng, Hui-Yuan; Viquez, Olga et al. (2015) Integrin α3β1 regulates kidney collecting duct development via TRAF6-dependent K63-linked polyubiquitination of Akt. Mol Biol Cell 26:1857-74
Kothiwale, Sandeepkumar; Borza, Corina M; Lowe Jr, Edward W et al. (2015) Discoidin domain receptor 1 (DDR1) kinase as target for structure-based drug discovery. Drug Discov Today 20:255-61
Borza, Corina M; Chen, Xiwu; Zent, Roy et al. (2015) Cell Receptor-Basement Membrane Interactions in Health and Disease: A Kidney-Centric View. Curr Top Membr 76:231-53
Williams, Ashley S; Kang, Li; Zheng, Jenny et al. (2015) Integrin α1-null mice exhibit improved fatty liver when fed a high fat diet despite severe hepatic insulin resistance. J Biol Chem 290:6546-57
Wang, Hongtao; Chen, Xiwu; Su, Yan et al. (2015) p47(phox) contributes to albuminuria and kidney fibrosis in mice. Kidney Int 87:948-62
Gangadhariah, Mahesha H; Luther, James M; Garcia, Victor et al. (2015) Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy. J Am Soc Nephrol 26:597-610

Showing the most recent 10 out of 22 publications